KLK15 is a new potential independent marker for unfavorable prognosis in ovarian cancer.

被引：0
|
作者：
Yousef, GM
Scorilas, A
Fracchioli, S
Iskander, L
Raouf, AA
Massobrio, M
Katsaros, D
Diamandis, EP
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Natl Ctr Sci Res, Athens, Greece
[3] Univ Turin, Turin, Italy
[4] Univ Toronto, Toronto, ON, Canada
[5] Menoufia Univ, Shibin Al Kawm, Egypt
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
D118
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 50 条
  • [31] Prognostic value of the human kallikrein gene 14 (KLK14) in ovarian cancer.
    Yousef, GM
    Scorilas, A
    Borgono, C
    Fracchioli, S
    Richiardi, G
    Massobrio, M
    Katsaros, D
    Diamandis, EP
    CLINICAL CHEMISTRY, 2002, 48 (06) : A25 - A26
  • [32] Activated matrix metalloproteinase-2 - A potential marker of prognosis for epithelial ovarian cancer
    Wu, XH
    Li, HL
    Kang, L
    Li, L
    Wang, WP
    Shan, B
    GYNECOLOGIC ONCOLOGY, 2002, 84 (01) : 126 - 134
  • [33] New biomarkers in cervical cancer. Predictive potential for prognosis and treatment response
    Kuebler, K.
    Domroese, C. M.
    Kuhn, W.
    GYNAKOLOGE, 2013, 46 (12): : 941 - 945
  • [34] Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data
    Batra, Jyotsna
    Lose, Felicity
    O'Mara, Tracy
    Marquart, Louise
    Stephens, Carson
    Alexander, Kimberly
    Srinivasan, Srilakshmi
    Eeles, Rosalind A.
    Easton, Douglas F.
    Al Olama, Ali Amin
    Kote-Jarai, Zsofia
    Guy, Michelle
    Muir, Kenneth
    Lophatananon, Artitaya
    Rahman, Aneela A.
    Neal, David E.
    Hamdy, Freddie C.
    Donovan, Jenny L.
    Chambers, Suzanne
    Gardiner, Robert A.
    Aitken, Joanne
    Yaxley, John
    Kedda, Mary-Anne
    Clements, Judith A.
    Spurdle, Amanda B.
    PLOS ONE, 2011, 6 (11):
  • [35] Serum proteins marker for early detection of ovarian cancer.
    Mor, G
    Visintin, I
    Zhao, H
    Schwartz, P
    Rutherford, T
    Yui, L
    Bray-Ward, P
    Ward, DC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 839S - 839S
  • [36] Higher platelet distribution width is associated with unfavorable prognosis in ovarian cancer
    Qin, Ling
    Li, Jia-Yu
    Huang, Wen-Juan
    Zhang, Meng-Lin
    Wang, Rui-Tao
    Shen, Wenjie
    CANCER BIOMARKERS, 2020, 28 (03) : 365 - 370
  • [37] Tissue prostate specific antigen:: An effective new marker for prognosis of early prostate cancer.
    Stege, R
    Grande, M
    Pousette, Å
    Tribukait, B
    Carlström, K
    JOURNAL OF UROLOGY, 1998, 159 (05): : 300 - 300
  • [38] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
    Manish KPal
    Shyam PJaiswar
    Vinaya NDwivedi
    Amit KTripathi
    Ashish Dwivedi
    Pushplata Sankhwar
    Cancer Biology & Medicine, 2015, 12 (04) : 328 - 336+338+337+339
  • [39] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
    Manish K.Pal
    Shyam P.Jaiswar
    Vinaya N.Dwivedi
    Amit K.Tripathi
    Ashish Dwivedi
    Pushplata Sankhwar
    Cancer Biology & Medicine, 2015, (04) : 328 - 336
  • [40] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
    Pal, Manish K.
    Jaiswar, Shyam P.
    Dwivedi, Vinaya N.
    Tripathi, Amit K.
    Dwivedi, Ashish
    Sankhwar, Pushplata
    CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 328 - 341
12345